129 related articles for article (PubMed ID: 2137556)
21. Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.
McSweeney PA; Wells DA; Shults KE; Nash RA; Bensinger WI; Buckner CD; Loken MR
Blood; 1996 Jul; 88(2):622-32. PubMed ID: 8695810
[TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of a CD5 positive, immunosuppressive human myeloma cell line.
Scibienski RJ; Paglieroni TG; MacKenzie MR
Leukemia; 1990 Nov; 4(11):775-80. PubMed ID: 1700238
[TBL] [Abstract][Full Text] [Related]
23. Membrane CD22 defines circulating myeloma-related cells as mature or later B cells.
Perfetti V; Vignarelli MC; Bellotti V; Glennie MJ; Zorzoli I; Ubbiali P; Obici L; Massa M; Ippoliti G; Ascari E; Merlini G
Lab Invest; 1997 Oct; 77(4):333-44. PubMed ID: 9354768
[TBL] [Abstract][Full Text] [Related]
24. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
25. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
[TBL] [Abstract][Full Text] [Related]
26. Cell-surface antigen expression in early and term gestation fetal hematopoietic progenitor cells.
Opie TM; Shields LE; Andrews RG
Stem Cells; 1998; 16(5):343-8. PubMed ID: 9766814
[TBL] [Abstract][Full Text] [Related]
27. CD74 is expressed by multiple myeloma and is a promising target for therapy.
Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
[TBL] [Abstract][Full Text] [Related]
28. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
[TBL] [Abstract][Full Text] [Related]
29. Induction of B-lymphocyte antigens on the chronic myeloid leukemic cell line K562 using sodium butyrate.
Fraser JK; Berridge MV
Exp Hematol; 1987 May; 15(4):406-13. PubMed ID: 2952519
[TBL] [Abstract][Full Text] [Related]
30. Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Jensen GS; Mant MJ; Belch AJ; Berenson JR; Ruether BA; Pilarski LM
Blood; 1991 Aug; 78(3):711-9. PubMed ID: 1830500
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies.
San Miguel JF; González M; Gascón A; Moro MJ; Hernández JM; Ortega F; Jimenez R; Guerras L; Romero M; Casanova F
Br J Haematol; 1991 Feb; 77(2):185-90. PubMed ID: 1706197
[TBL] [Abstract][Full Text] [Related]
32. Myelomonocytic antigen positive multiple myeloma.
Grogan TM; Durie BG; Spier CM; Richter L; Vela E
Blood; 1989 Feb; 73(3):763-9. PubMed ID: 2644987
[TBL] [Abstract][Full Text] [Related]
33. Cellular origins of hematologic neoplasms.
Buchsbaum RJ; Schwartz RS
N Engl J Med; 1990 Mar; 322(10):694-6. PubMed ID: 2304495
[No Abstract] [Full Text] [Related]
34. Expression of the neural cell adhesion molecule (CD56) by human myeloma cells.
Drach J; Gattringer C; Huber H
Clin Exp Immunol; 1991 Mar; 83(3):418-22. PubMed ID: 1706237
[TBL] [Abstract][Full Text] [Related]
35. Biology and bioinformatics of myeloma cell.
Abroun S; Saki N; Fakher R; Asghari F
Lab Hematol; 2012 Dec; 18(4):30-41. PubMed ID: 23253865
[TBL] [Abstract][Full Text] [Related]
36. Reactive histiocytosis: a diagnostic dilemma in multiple myeloma.
Singh Sachdeva MU; Das R; Ahluwalia J; Varma N
Indian J Pathol Microbiol; 2010; 53(3):577-8. PubMed ID: 20699538
[No Abstract] [Full Text] [Related]
37. [Hematopoietic malignancy (leukemia, malignant lymphoma, multiple myeloma)].
Nosaka K; Kawaguchi T
Nihon Rinsho; 2012 May; 70(5):835-9. PubMed ID: 22620009
[TBL] [Abstract][Full Text] [Related]
38. Expression of CD66a in multiple myeloma.
Satoh Y; Hayashi T; Takahashi T; Itoh F; Adachi M; Fukui M; Kuroki M; Kuroki M; Imai K; Hinoda Y
J Clin Lab Anal; 2002; 16(2):79-85. PubMed ID: 11948796
[TBL] [Abstract][Full Text] [Related]
39. Human endometrial stromal cells and decidual cells express cluster of differentiation (CD) 13 antigen/aminopeptidase N and CD10 antigen/neutral endopeptidase.
Imai K; Maeda M; Fujiwara H; Okamoto N; Kariya M; Emi N; Takakura K; Kanzaki H; Mori T
Biol Reprod; 1992 Mar; 46(3):328-34. PubMed ID: 1352146
[TBL] [Abstract][Full Text] [Related]
40. Multiple hematopoietic-cell lineages in multiple myeloma.
Shpilberg O; Modan M; Modan B; Ramot B
N Engl J Med; 1990 Jul; 323(4):277. PubMed ID: 2366839
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
